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Of the many major achievements in cell biology during the last 25 years, none is more im-
portant than the understanding of regulation of cell cycles. In 1953 two fundamental observa-
tions concerning DNA were made. Watson and Crick suggested that the three-dimensional 
structure of DNA exists as a double helix with specific base pairings, and Howard and Pelc 
observed that DNA is replicated during a specific phase in the mitotic cycle. Thus developed 
the theory of cell cycles. 
Next, investigators explored which events occur during each phase of the cycle and what 
controls the readout of the genes for proliferation or differentiation. In 1961, Jacob and 
Monod proposed that for prokaryotic cells the operon is the mechanism which controls the 
readout of the genes; and by the end of the 1960s, several investigators had defined the role of 
cyclic AMP and its mechanism of action at the gene level. 
The control mechanisms for eukaryotic cells are less well defined . Basi.cally there are two 
types of regulatory molecules: those that arrive at the cell surface and send messages inside 
the cell; and those that enter the cell, bind to receptors , and then enter the nucleus to 
interact with the genes. During the past five to ten years, the cell surface and its receptors 
have received considerable attention as the recognition and control areas for cell proliferation 
and differentiation, and currently the role of the cyclic nucleotides and prostaglandins is be-
ing investigated. Various model systems are now available for detailed studies of these con-
trol mechanisms. 
EARLY DISCOVERIES 
In 1953, Watson and Crick [1] published one of 
the most important deductive discoveries in molec-
ular biology, namely that the three-dimensional 
structure of DNA consists of specific base pairings 
which form a double helix. This knowledge led to a 
much more systematic investigation than had been 
possible before into the mechanisms which control 
the synthesis, mode of expression, and degradation 
of DNA. Since DNA is the genetic material of the 
cell, its interrelation with the cell cycle is ex-
tremely important. 
The experiments of Howard and Pelc [2], which 
were also published in 1953, used 32P-labeled 
sodium phosphate as a precursor of DNA and 
demonstrated that cells replicate DNA only during 
a specific phase of the mitotic cycle. These experi-
ments laid the foundation for the development of 
the cell cycle concept. Figure 1 illustrates the cell 
cycle that was modified by Patt and Quastler [3] to 
include the Go or, as some investigators theorize, 
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cAMP: 3' ,5 '-cyclic adenosine monophosphate 
'cGMP: 3',5' -cyclic guanosine monophosphate 
G j : gap-l of the cell cycle, etc. 
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prolonged G1 phase of the cell. The gap-1 (GJ 
phase of the cell cycle occurs between the end of 
mitosis and the initiation of DNA synthesis in the 
next cycle. The synthetic phase is represented by 
S; the gap-2 (G 2 ) phase occurs between the end of 
DNA synthesis and the beginning of mitosis. The 
mitotic phase (M) is composed of prophase, meta-
phase, anaphase, and telophase. The most impor-
tant phase of the cell cycle, at least with respect to 
the regulatory phenomena within the cycle, is 
probably G 1 [4,5]; some regulation, however, may 
occur during the G2 phase. Thus, tissue functions 
and differentiation may be regulated by differen-
tial gene activation as well as by cell cycle progres-
SIOn. 
Electron microscopy and analytical and pre-
parative centrifugation have made possible a sys-
tematic analysis of cell biology. By means of these 
techniques, ribosomes, polysomes, various cellular 
components, and DNA have been isolated and 
identified. Moreover, various components of the 
cell have been biochemically and ultrastructurally 
correlated and dissected, and the regulatory con-
trols of these phenomena have been investigated. 
CONTROLS IN PROKARYOTES 
Much of our information about fine control at 
the level of DNA was first obtained around the 
time of World War II when the genetic history of 
16 VOORHEES ET AL 
OPERATOR STRUCTURAL 
GENE GENES 
o A 
T 1 
SITE FOR • ,,"'" 
REPRESSION 1 
OR 
INDUCTION WAWW. 
8 
1 
VJJJIJ 
1 
--
C 
1 
• II. III II" II' 
1 
--
GENES 
MESSENGER RNA 
PROTEINS 
FIG. 1. The operon model proposed by Jacob and 
Monod [6] for the control of gene readout in prokaryotic 
cells. 
bacteria was beginning. As part of their experi-
ments on the molecular biology of the gene, Jacob 
and Monod isolated spontaneous mutant and wild 
types of bacteria. Figure 2 is a schematic represen-
tation of their work which was finalized in their 
theory of the operon [6]. In a eukaryotic organism 
such as man, a system analogous to but not 
identical with the bacterial system may exist. The 
function of gene regulation, both in microbes and in 
man, is to develop a repertoire of proteins that are 
characteristic of any given tissue or organism. In 
bacteria, this regulation is mainly related to the 
ecosystem, i.e., to the availability of nutrients. For 
example, if a bacterium is growing in glucose, a 
certain enzymatic profile ensues; if it is placed in 
lactose, certain enzymes appropriate to the utiliza-
tion of lactose are induced. Thus, the microbe 
modulates its enzymatic machinery to adapt to 
en vironmen tal circumstances. 
Magasanik [7] labeled the ability of glucose to 
inhibit the induction of lactose-metabolizing en-
zymes catabolite repression, and Makman and 
Sutherland [8] showed that the addition of glucose 
to a bacterial culture results in an 80% decrease in 
the cAMP (3',5'-cyclic adenosine monophosphate) 
content of the cells in less than 2 min. Apparently a 
rise in the cAMP content of bacteria was corre-
lated with its adaptation to nutritional diversity or 
environmental adversity. The mechanism behind 
this phenomenon was unraveled by the experi-
ments of Zubay and Chambers [9] who showed 
that for the derepression to occur, cAMP had to 
bind to a particular protein called catabolite gene 
activator protein. The regulatory complex, com-
posed of core RNA polymerase (with its 4 sub-
units), the sigma factor, the cAMP gene activator 
protein combined to cAMP all attach at the 
promoter site to permit the readout of messenger 
RNA [9]. In a cell-free DNA-directed protein 
synthesizing system, cAMP was essential for the 
readout of the genes coding for the synthesis of 
tJ-galactosidase which are controlled by the lactose 
operon [10]. This was probably the first demon-
stration that a protein with biologic activity could 
be synthesized from a gene template in a test tube. 
POSSIBLE CONTROLS IN EUKARYOTES 
Steroids 
The cAMP receptor protein (CAP protein) of 
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FIG. 2. The cell cycle originally suggested by Howard 
and Pelc [2] and later revised by Patt and Quastler [3] to 
include the Go component. 
prokaryotic organisms may be analagous to cyto-
plasmic steroid receptors in mammalian cells. 
Glucocorticoids and sex steroids penetrate a cell 
and bind to a receptor molecule [11]. The recep-
tor-steroid complex is then translocated into the 
nucleus where it regulates genetic expression [12]. 
How this steroid regulation functions in various 
mammalian cells is still a matter of considerable 
controversy. 
Gene Repression 
The genome of a prokaryotic cell and its regula-
tion are much simpler than those of eukaryotic 
cells. During differentiation, the control mecha- . 
nism may be a permanent repression of gene 
activity or the genetic material may be lost by 
some process such as enzymatic degradation. In an 
elegant experiment, Gurdon [13] demonstrated 
gene repression. The nucleus of an epithelial cell 
from a frog intestine, which is a highly differenti-
ated cell, was removed and placed into the cyto-
plasm of an enucleated frog egg. The fact that a 
normal frog developed clearly demonstrated that 
the nucleus contained all of the genes necessary for 
the development of a complete organism . Prolifera-
tive disease states may be due to the activation of 
these proliferative genes which are normally re-
pressed (cells in Go) or to increased proliferation 
among the cells in the cycle. 
It is evident that genes are regulated. The 
question is how are they regulated in mammalian 
cells? In the spring of 1973, at a conference on the 
control of proliferation in animal cells held at Cold 
Spring Harbor [14], we described some of our work 
on psoriasis as a model of increased cell prolifera-
tion [15]. Since a single regulatory molecule proba-
bly cannot control the complicated set of events 
that trigger proliferation, an orchestrated set of 
variables must regulate the commitment of cells to 
pass from a resting state into the cell cycle and 
must then "set" the rate of the cell cycle in vivo. 
These effector molecules may also serve as the 
signal which shifts a cell into the specialized 
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compartment (spinous or granular layer of an 
epidermis) from which, under normal conditions, it 
never returns to the proliferative state. 
Cell Surface 
In bacteria, such environmental factors as car-
bon source and temperature are probably the most 
important signals for modulating the basic cell 
cycle; in the multicellular eukaryotic organisms, 
however, these environmental factors are probably 
less important than many other factors. During the 
last several years, a series of these factors has been 
isolated or identified which affects growth and 
differentiation in eukaryotic cells. Basically, there 
are two types of regulatory molecules or signals: 
one arrives at the cell surface and sends messages 
inside the cell; in the other, the hormone itself 
enters the cell and binds to cytoplasmic receptor 
molecules. 
The first type can be subdivided into three 
components: the incoming signal to the cell sur-
face, the role of the cell surface itself, and the 
intracellular switches and responses that result 
from these pertubations. The incoming signals to 
the cell surface are the various small molecules 
such as catecholamines, acetylcholine, other 
neurotransmitters, and the peptide hormones. 
In addition to receptor sites for the hormones, 
the cell surface also contains glycoproteins which 
act as specific cell recognition factors [16,17]. Two 
systems which illustrate this point are the embry-
onic neural retina cells and the sponges . A tissue-
specific cell recognition factor, which has been 
purified and characterized from embryonic neural 
retina cells [18], appears to enable these cells to 
recognize each other and to "sort out" to form an 
aggregate. Apparently, the protein portion of the 
cell surface glycoprotein is the component that 
maintains the recognition factor activity. In the 
other system, two different species of sponges with 
different natural color were dissociated into indi-
vidual cells and then mixed together to re-form 
into species-specific aggregates [17). In this sys-
tem the carbohydrate moieties are important for 
the 'cell surface components to be effective as an 
aggregation factor . These types of ~~peri.ments 
indicate that cell and/or tissue recogmtIOn factors 
do occur on the cell surface and may play an 
important role in the regulation of cell proliferation 
and/or differentiation. 
Other components of the cell surface such as 
\-irus, lectin, and acetylcholine receptors and such 
antigens as HLA and blood group substances may 
be associatd with positive proliferative events 
1.'ihereas the so-called chalone system may be the 
inhibitory factor in some tissues. It is not known 
vhether the chalone system is similar to the 
' issue-specific recognition or aggregating factors. 
Soluble Factors 
Several soluble factors which promote mitosis 
instead of mitogenic growth and differentiation 
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have been isolated from the pituitary gland [19), 
fibroblasts [20], and platelets [21]. In wound 
healing, during which the platelets plug up the 
hole in the endothelium, one or other of these fac-
tors may be released and may stimulate epidermal 
cell proliferation. 
Cyclic Nucleotides 
Cyclic AMP. An important consideration con-
cerns the intracellular mechanisms and switches 
that are activated by the perturbations on the cell 
surface. The elucidation of this second messenger 
system constituted one of the great advances in 
control mechanisms in general. Certain hormones 
arrive at the cell surface, attach to a receptor , and, 
possibly under the influence of a transduction 
system, modulate the enzyme adenyl ate cyclase 
which catalyzes the formation of cAMP from 
adenosine triphosphate (ATP) . cAMP binds to the 
receptor subunit of cAMP-dependent protein ki-
nase, and as a result the catalytic subunit is 
dissociated from the receptor subunit. The former 
then catalyzes the transfer of the terminal phos-
phate of ATP to any number of substrates within 
the cell. This phosphorylation then alters the 
activity of an enzyme (e.g., glycogen phosphoryl-
ase) or may alter the tightness of binding (histones 
or acidic nuclear proteins) to DNA. 
Cyclic GMF. Within the past few years, a second 
cyclic nucleotide system, cGMP (3' ,5' -cyclic gua-
nosine monophosphate), has emerged as a possible 
agent that controls proliferation and/or differentia-
tion. Thes~ two systems are parallel, at least in 
terms of the enzymes (adenylate and guanylate 
cyclases) that form the two cyclic nucleotides and 
of the cyclic phosphodiesterases that hydrolyze the 
cyclic nucleotides to their respective 5' nucleotides . 
Whether the parallelism continues beyond this 
point in all tissues is an open question since little is 
known about cGMP. The relation of cAMP and 
cGMP to cell proliferation is still a matter of some 
controversy. According to some evidence, cAMP 
regulates cell proliferation by restraining growth in 
many in vitro systems and in some in vivo systems 
[22,23). In most of the in vitro experiments, the 
elevation of cAMP inhibited cell proliferation, but 
in several studies, e.g., in thymocytes [24), in bone 
marrow stem cells [25], and in regenerating liver 
[24], just the opposite occurred. In those cases 
where cAMP did inhibit proliferation, abundant 
data suggest that the restraint occurred in the G 1 
phase of the cell cycle and in many cases in the G 2 
phase also [22,26,27]. In the epidermis, cAM~ 
restrains in the G 2 phase [28,29]; whether It 
restrains in the G 1 phase is not clear at this time. 
All proliferating cell systems were associated in 
the past with elevated levels of cGMP [30,31). In 
addition, Chambers, Martin, and Weinstein have 
demonstrated in the lymphocyte system that ex-
ogenously added cGMP also elicited a weak mito-
genic response by an unknown mechanism [32]. 
Recently, however, Miller, Lovelace, Gallo, and 
18 VOORHEES ET AL 
Pastan obtained four cell lines of transformed 
fibroblasts which contain no detectable levels of 
cG MP [33]. As a result of these conflicting data, 
elevated levels of cGMP seem to occur only in some 
proliferating systems. Goldberg, the originator of 
the dualistic hypothesis of cAMP and cGMP 
action in cell control [34], recognized that in some 
situations these two cyclic nucleotides act unidi-
rectionally, i.e., increased concentrations of either 
nucleotide initiate the event. Whether the control 
system in the epidermis is bidirectional is still not 
clear. In general, however, a bidirectional system 
functions during cell proliferation, i.e., cAMP 
inhibits and cGMP stimulates proliferation. 
Prostaglandins 
Whether the cyclic nucleotides and prostagland-
ins are related is being studied at the present time. 
Some early investigations into the effects of prosta-
glandins on the epidermis were conducted by 
Ziboh and Hsia [35] who used as a model essential 
fatty acid deficiency in rats. The investigations of 
Hamberg and Samuelsson [36] and Hamberg, 
Svensson, and Samuelsson [37] have elucidated a 
new cascade of reactions to arachidonic acid, the 
precursor of prostaglandin E2 and F 2". A series of 
compounds, such as BETE, thromboxane, and 
several new prostaglandins in addition to the A, B, 
E, and F series, has also been identified in some 
tissues. More recently, we have collaborated with 
Samuelsson and his colleagues on a study about 
the prostaglandin system, using psoriasis as a 
model of proliferative disease. The data indicate 
that free arachidonic acid and HETE levers are 
much higher in the lesion than in the uninvolved 
areas and that the levels of prostaglandin E2 and 
F 20 are minimally increased in the lesions [38 J. 
In summary, it should be apparent that a 
proliferative program is operable in cells and that 
the principal regulatory event or events probably 
occur in the G 1 phase of the cell cycle. Some other 
factors that have not been mentioned but may be 
important in the proliferative program are histone 
phosphorylation, the synthesis and phosphoryla-
tion of acidic nuclear proteins, allosteric activation 
of inducible phosphoribosylpyrophosphate synthe-
tase (the rate-limiting enzyme system for purine 
biosynthesis), RNA synthesis, and polyamine syn -
thesis via regulation of ornithine decarboxylase. 
CHARACTERISTICS OF MODEL SYSTEMS 
Further investigations to determine how the cell 
cycle is controlled depend on the development of 
good model systems in which the regulatory points 
and the effector molecules at these points can be 
dissected as the cells progress through the cycle. 
We believe that the ideal model should have the 
following characteristics: (1) it should be easily 
obtainable, (2) it should be capable of in vitro ~in 
vivo manipulation, (3) its basic metabolism must 
be understood, (4) the regulators of the basic 
metabolism must be known, and (5) it must be 
genetically manipulatable. 
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Several current systems have some of these 
characteristics and are satisfactory models for 
investigating certain aspects of cell regulation. The 
slime mold, Dictyostelium discoideum, is an excel-
lent model from the point of view of developmental 
biology. The lymphocyte provides a system for 
studying the Go -+ G 1 transition. Primary cell cul-
tures and cell strains provide relatively normal 
material that is easily manipulatable and can be 
synchronized. Finally, the melanoma and neuro-
blastoma cell lines are excellent systems for study-
ing proliferation and differentiation. 
The available epidermal systems lack some of 
the desired characteristics listed above. The cur-
rent in vitro systems are slice preparations, 
primary epidermal cell cultures, and cell strain 
and cell line cultures. A combination of tech-
niques, such as primary cultures coupled with 
somatic cell genetics, provides a powerful tool for 
determining how the cell cycle in the epidermis is 
regulated. Two in vivo models, which appear to be 
excellent for future investigations into the regula-
tion of the cell cycle in skin disease, are the nude 
mouse [39] and animals deficient in essential fatty 
acids [35 J. 
Other in vivo systems which may yield valuable 
information into control mechanisms are investiga-
tions into or correlations with (1) normal animal 
information, (2) adaptive changes that occur from 
fetal to neonatal life, (3) closer investigations of 
alterations during human diseases, and (4) data 
obtained in comparative biology and biochemistry. 
Further understanding of the control mechanisms 
will depend on new technical advances and new 
applications of available techniques to the prob-
lems related to the regulation of the cell cycle. 
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